BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

980 related articles for article (PubMed ID: 32436996)

  • 1. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
    Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
    Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of cancer patients with COVID-19.
    Yang F; Shi S; Zhu J; Shi J; Dai K; Chen X
    J Med Virol; 2020 Oct; 92(10):2067-2073. PubMed ID: 32369209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
    Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
    Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.
    Cai YQ; Zhang XB; Zeng HQ; Wei XJ; Hu L; Zhang ZY; Ming Q; Peng QP; Chen LD
    Aging (Albany NY); 2021 Sep; 13(17):20896-20905. PubMed ID: 34495869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, China.
    Sun L; Shen L; Fan J; Gu F; Hu M; An Y; Zhou Q; Fan H; Bi J
    J Med Virol; 2020 Oct; 92(10):2055-2066. PubMed ID: 32369208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China.
    Yao Y; Chen W; Wu X; Shen L; Shen L; Fu Y; Yang Q; Yao M; Zhou J; Zhou H
    Clin Microbiol Infect; 2020 Oct; 26(10):1380-1385. PubMed ID: 32593742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of factors for disease progression in 61 patients with COVID-19 in Xiaogan, Hubei, China.
    Xing Y; Wang H; Yao XH; Li Y; Huang JT; Tang J; Zhu S; Liu YQ; Xiao J
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12490-12499. PubMed ID: 33336768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe
    Wang K; Wang X; Du J; Liu C; Jiang Y; Zhang H; Jiang H; Fu Q
    Epidemiol Infect; 2021 Mar; 149():e81. PubMed ID: 33775266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19.
    Torun A; Çakırca TD; Çakırca G; Portakal RD
    Rev Assoc Med Bras (1992); 2021 Mar; 67(3):431-436. PubMed ID: 34468610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
    Gao Y; Li T; Han M; Li X; Wu D; Xu Y; Zhu Y; Liu Y; Wang X; Wang L
    J Med Virol; 2020 Jul; 92(7):791-796. PubMed ID: 32181911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
    Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 49.